✦ LIBER ✦

VX 770 may be effective in cystic fibrosis

Book ID: 120844328
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816320-00016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of VX-770 in Persons with Cystic

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation

✍ Accurso, Frank J.; Rowe, Steven M.; Clancy, J.P.; Boyle, Michael P.; Dunitz, Jor 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 760 KB

Denufosol may be beneficial in cystic fi

Denufosol may be beneficial in cystic fibrosis

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

61* VX-770 in subjects with cystic fibro

61* VX-770 in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation

✍ P.A. Flume; D.S. Borowitz; T.G. Liou; H. Li; K. Yen; C.L. Ordonez; D.E. Geller 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Anti-inflammatory drugs may be underused

Anti-inflammatory drugs may be underused in cystic fibrosis

✍ Hannah Wunsch 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 77 KB

Cystic fibrosis: enhanced theophylline m

Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease

✍ Knoppert, David C; Spino, Michael; Beck, Raphael; Thiessen, Jake J; MacLeod, Stu 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 918 KB

Cystic fibrosis may be explained by a pr

Cystic fibrosis may be explained by a primary defect in fatty acid metabolism

✍ Freedman, S.D.; Katz, M.H.; Parker, E.M.; Laposata, M.; Urman, M.Y.; Alvarez, J. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 175 KB